Erich L. Grimm

2.2k total citations
39 papers, 1.7k citations indexed

About

Erich L. Grimm is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Erich L. Grimm has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 17 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Erich L. Grimm's work include Cell death mechanisms and regulation (7 papers), Synthetic Organic Chemistry Methods (7 papers) and Inflammatory mediators and NSAID effects (6 papers). Erich L. Grimm is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Synthetic Organic Chemistry Methods (7 papers) and Inflammatory mediators and NSAID effects (6 papers). Erich L. Grimm collaborates with scholars based in Canada, United States and Germany. Erich L. Grimm's co-authors include Donald W. Nicholson, Yongxin Han, Sophie Roy, Renée Aspiotis, Steven Xanthoudakis, Paul E. Swanson, Richard S. Hotchkiss, Kevin W. Tinsley, Cheryl A. Black and Irene E. Karl and has published in prestigious journals such as Journal of Neuroscience, Nature Immunology and Analytical Biochemistry.

In The Last Decade

Erich L. Grimm

38 papers receiving 1.6k citations

Peers

Erich L. Grimm
Alan L. Maycock United States
Rajesh Devraj United States
Mark Namchuk United States
Richard Hajdu United States
Akinori Arimura Japan
Jeffrey C. Boehm United States
Tomohiro Kawamoto Japan
Hiroyuki Miyachi Japan
Sonia Lobo Planey United States
Jamshid Davoodi Iran
Alan L. Maycock United States
Erich L. Grimm
Citations per year, relative to Erich L. Grimm Erich L. Grimm (= 1×) peers Alan L. Maycock

Countries citing papers authored by Erich L. Grimm

Since Specialization
Citations

This map shows the geographic impact of Erich L. Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erich L. Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erich L. Grimm more than expected).

Fields of papers citing papers by Erich L. Grimm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erich L. Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erich L. Grimm. The network helps show where Erich L. Grimm may publish in the future.

Co-authorship network of co-authors of Erich L. Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Erich L. Grimm. A scholar is included among the top collaborators of Erich L. Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erich L. Grimm. Erich L. Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cauchon, Elizabeth, Austin Chen, Amandine Chefson, et al.. (2012). Design and synthesis of potent, isoxazole-containing renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(8). 2670–2674. 9 indexed citations
2.
Aspiotis, Renée, Elizabeth Cauchon, Austin Chen, et al.. (2012). 3,4-Diarylpiperidines as potent renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 1953–1957. 6 indexed citations
3.
Aspiotis, Renée, Austin Chen, Elizabeth Cauchon, et al.. (2011). The discovery and synthesis of potent zwitterionic inhibitors of renin. Bioorganic & Medicinal Chemistry Letters. 21(8). 2430–2436. 7 indexed citations
4.
Lévesque, Jean-François, Kelly Bleasby, Amandine Chefson, et al.. (2011). Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Bioorganic & Medicinal Chemistry Letters. 21(18). 5547–5551. 9 indexed citations
5.
Chen, Austin, Daniel Dubé, Sébastien Gagné, et al.. (2010). Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study. Bioorganic & Medicinal Chemistry Letters. 20(17). 5074–5079. 12 indexed citations
6.
Isabel, Élise, Renée Aspiotis, W. Cameron Black, et al.. (2007). Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinones. Bioorganic & Medicinal Chemistry Letters. 17(6). 1671–1674. 9 indexed citations
7.
Grimm, Erich L., Christine Brideau, Nathalie Chauret, et al.. (2006). Substituted coumarins as potent 5-lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2528–2531. 44 indexed citations
8.
Mellon, Christophe, Renée Aspiotis, Christopher I. Bayly, et al.. (2005). Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(17). 3886–3890. 10 indexed citations
9.
Riendeau, Denis, Renée Aspiotis, Diane Ethier, et al.. (2005). Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886. Bioorganic & Medicinal Chemistry Letters. 15(14). 3352–3355. 125 indexed citations
10.
Grimm, Erich L., Bruno Roy, Renée Aspiotis, et al.. (2004). Solid phase synthesis of selective caspase-3 peptide inhibitors. Bioorganic & Medicinal Chemistry. 12(5). 845–851. 12 indexed citations
11.
Tawa, Paul, Kai Hell, André Giroux, et al.. (2004). Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors. Cell Death and Differentiation. 11(4). 439–447. 91 indexed citations
12.
Black, W. Cameron, Christine Brideau, Chi-Chung Chan, et al.. (2003). 3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 13(6). 1195–1198. 29 indexed citations
13.
Han, Yongxin, André Giroux, Erich L. Grimm, et al.. (2003). Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(3). 805–808. 23 indexed citations
14.
Isabel, Élise, W. Cameron Black, Christopher I. Bayly, et al.. (2003). Nicotinyl aspartyl ketones as inhibitors of caspase-3. Bioorganic & Medicinal Chemistry Letters. 13(13). 2137–2140. 18 indexed citations
15.
Hotchkiss, Richard S., K. Chang, Paul E. Swanson, et al.. (2000). Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nature Immunology. 1(6). 496–501. 452 indexed citations
16.
Nicoll‐Griffith, Deborah A., James A. Yergey, Laird A. Trimble, et al.. (2000). Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx™). Bioorganic & Medicinal Chemistry Letters. 10(23). 2683–2686. 33 indexed citations
17.
Black, W. Cameron, Christine Brideau, S. Charleson, et al.. (1999). A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(22). 3181–3186. 23 indexed citations
18.
LEBLANC, Y., Patrick Roy, S. Boyce, et al.. (1999). SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor. Bioorganic & Medicinal Chemistry Letters. 9(15). 2207–2212. 38 indexed citations
19.
Grimm, Erich L., et al.. (1993). Facile construction of the bicyclo[6.4.0]dodecane ring system via intramolecular cyclization of a sulfone stabilized carbanion. Tetrahedron Letters. 34(44). 7017–7018. 11 indexed citations
20.
Grimm, Erich L., et al.. (1986). Intramolekulare Diels-Alder-Reaktionen mit 2-Trimethylsiloxy-2-vinylcyclopropancarbonsäure-estern als Schlüsselbausteinen. Angewandte Chemie. 98(12). 1104–1105. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan L. Maycock Breakdown of academic impact, for papers by Rajesh Devraj Breakdown of academic impact, for papers by Mark Namchuk Breakdown of academic impact, for papers by Richard Hajdu Breakdown of academic impact, for papers by Akinori Arimura Breakdown of academic impact, for papers by Jeffrey C. Boehm Breakdown of academic impact, for papers by Tomohiro Kawamoto Breakdown of academic impact, for papers by Hiroyuki Miyachi Breakdown of academic impact, for papers by Sonia Lobo Planey Breakdown of academic impact, for papers by Jamshid Davoodi
Rankless by CCL
2026